相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
Gulab Sher et al.
SEMINARS IN CANCER BIOLOGY (2022)
Specific expression and functions of circular RNAs
Sema Misir et al.
CELL DEATH AND DIFFERENTIATION (2022)
Exosomes as a new frontier of cancer liquid biopsy
Dan Yu et al.
MOLECULAR CANCER (2022)
Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast Cancers
Xuelin Xia et al.
NANO-MICRO LETTERS (2022)
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
Paolo Tarantino et al.
NPJ BREAST CANCER (2022)
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
Miguel Garcia-Pardo et al.
BRITISH JOURNAL OF CANCER (2022)
Liquid-Liquid Phase Separation in Cancer Signaling, Metabolism and Anticancer Therapy
Sebastian Igelmann et al.
CANCERS (2022)
Biorecognition Engineering Technologies for Cancer Diagnosis: A Systematic Literature Review of Non-Conventional and Plausible Sensor Development Methods
Kalaumari Mayoral-Pena et al.
CANCERS (2022)
Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations
Asmaa Y. Abuhamad et al.
CELLS (2022)
Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs
Miguel Angel Olmedo-Suarez et al.
BIOMOLECULES (2022)
In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
Peng Ji et al.
SCIENCE ADVANCES (2022)
Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
Song Xia et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
Maarten H. Geurts et al.
LIFE SCIENCE ALLIANCE (2021)
Predicting the efficiency of prime editing guide RNAs in human cells
Hui Kwon Kim et al.
NATURE BIOTECHNOLOGY (2021)
Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review
Agata Szymiczek et al.
CLINICAL GENETICS (2021)
The E3 ubiquitin-protein ligase Rbx1 regulates cardiac wall morphogenesis in zebrafish
Pourya Sarvari et al.
DEVELOPMENTAL BIOLOGY (2021)
Biomolecular condensates at sites of DNA damage: More than just a phase*,**
Vincent Spegg et al.
DNA REPAIR (2021)
Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer
Haruka Yamaguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)
Mohammed Awal Issah et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
Otilia Menyhart et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Advanced Approaches to Breast Cancer Classification and Diagnosis
M. Zubair et al.
FRONTIERS IN PHARMACOLOGY (2021)
Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis
Xiaoyu Zeng et al.
SCIENTIFIC REPORTS (2021)
Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer
Nannan Liu et al.
BMC CANCER (2021)
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics
Anna D. Louie et al.
FRONTIERS IN PHARMACOLOGY (2021)
Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer: In silico Screening of Therapeutic Compounds and in vitro Characterization
Saisai Tian et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
Wen Yin et al.
PHARMACEUTICS (2021)
Histone variants at a glance
Paul B. Talbert et al.
JOURNAL OF CELL SCIENCE (2021)
Epigenetic inheritance and evolution: a historian's perspective
Laurent Loison
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2021)
Carnosol Is a Novel Inhibitor of p300 Acetyltransferase in Breast Cancer
Halima Alsamri et al.
FRONTIERS IN ONCOLOGY (2021)
The roles of epigenetics in cancer progression and
Jocelyn F. Chen et al.
BIOCHEMICAL JOURNAL (2021)
A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment
Tengteng Zou et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Prime editing - an update on the field
Janine Scholefield et al.
GENE THERAPY (2021)
Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Yuhao Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy
Meiou Dai et al.
NATURE COMMUNICATIONS (2021)
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
Chunhong Hu et al.
CLINICAL EPIGENETICS (2021)
Near infrared photoimmunotherapy for cancers: A translational perspective
Yasuhiro Maruoka et al.
EBIOMEDICINE (2021)
Breast Cancer Aptamers: Current Sensing Targets, Available Aptamers, and Their Evaluation for Clinical Use in Diagnostics
Kathleen Varty et al.
CANCERS (2021)
Decoding LncRNAs
Lidia Borkiewicz et al.
CANCERS (2021)
The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
Xiaolong Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Shreelaxmi Gavas et al.
NANOSCALE RESEARCH LETTERS (2021)
Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders
Vincenza Aliperti et al.
NON-CODING RNA (2021)
Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression
Pan Gao et al.
GENOME BIOLOGY (2021)
The role of m6A modification in the biological functions and diseases
Xiulin Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise
Daphne Morel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Methods for analysis of circular RNAs
Poonam R. Pandey et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition
Li-Ting Wang et al.
EMBO REPORTS (2020)
A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy
Ranjana K. Kanchan et al.
MOLECULAR CANCER (2020)
Role of HDACs in normal and malignant hematopoiesis
Pan Wang et al.
MOLECULAR CANCER (2020)
The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu et al.
NUCLEIC ACIDS RESEARCH (2020)
HDAC3 functions as a positive regulator in Notch signal transduction
Francesca Ferrante et al.
NUCLEIC ACIDS RESEARCH (2020)
METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression
Dandan Yi et al.
ONCOLOGY REPORTS (2020)
Breast cancer early detection: A phased approach to implementation
Ophira Ginsburg et al.
CANCER (2020)
Protein Histidine Methylation
Sebastian Kwiatkowski et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2020)
Modulation of circRNA Metabolism by m6A Modification
Gaia Di Timoteo et al.
CELL REPORTS (2020)
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo et al.
GENES (2020)
Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors
Duran Sueruen et al.
GENES (2020)
Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance
Margaret L. Dahn et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
Flavia Lima Costa Faldoni et al.
CELLS (2020)
Advances of epigenetic editing
Rutger A. F. Gjaltema et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
Jiayu Zhang et al.
CANCERS (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
Partitioning of cancer therapeutics in nuclear condensates
Isaac A. Klein et al.
SCIENCE (2020)
Partitioning of Chemotherapeutics into Nuclear Condensates-Opening the Door to New Approaches for Drug Development
Thomas P. Howard et al.
MOLECULAR CELL (2020)
The roles of long noncoding RNAs in breast cancer metastasis
Lingxia Liu et al.
CELL DEATH & DISEASE (2020)
Prime editing for functional repair in patient-derived disease models
Imre F. Schene et al.
NATURE COMMUNICATIONS (2020)
Cell-free DNA concentration in patients with clinical or mammographic suspicion of breast cancer
Michal Peled et al.
SCIENTIFIC REPORTS (2020)
Genome Edited Crops Touch the Market: A View on the Global Development and Regulatory Environment
Jochen Menz et al.
FRONTIERS IN PLANT SCIENCE (2020)
Non-Invasive Biomarkers for Early Detection of Breast Cancer
Jiawei Li et al.
CANCERS (2020)
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Circular RNA: metabolism, functions and interactions with proteins
Wei-Yi Zhou et al.
MOLECULAR CANCER (2020)
Challenges and achievements of liquid biopsy technologies employed in early breast cancer
Alfonso Alba-Bernal et al.
EBIOMEDICINE (2020)
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer
Ming Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
An integrative multi-omics network-based approach identifies key regulators for breast cancer
Yi-Xiao Chen et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: A Literature Review
Yu-Ting Lee et al.
EPIGENOMES (2020)
Perspectives on the Role of Histone Modification in Breast Cancer Progression and the Advanced Technological Tools to Study Epigenetic Determinants of Metastasis
Jialang Zhuang et al.
FRONTIERS IN GENETICS (2020)
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer
Alexander Ring et al.
BMC CANCER (2020)
Prime editing efficiently generates W542L and S621I double mutations in two ALS genes in maize
Yuan-Yuan Jiang et al.
GENOME BIOLOGY (2020)
Circular RNAs are abundant and dynamically expressed during the embryonic lung development of C57BL/6 mice
Meng-Jie Zhang et al.
HELIYON (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Histone methylation and the DNA damage response
Fade Gong et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2019)
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
Bernardo P. de Almeida et al.
BMC CANCER (2019)
The role of histone deacetylase inhibitors in metastatic breast cancer
Bruna Zucchetti et al.
BREAST (2019)
Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
Meran Keshawa Ediriweera et al.
DRUG DISCOVERY TODAY (2019)
Cancer epigenetics in solid organ tumours: A primer for surgical oncologists
Thomas M. Drake et al.
EJSO (2019)
Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view
Alexis Vallard et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Life and death of circulating cell-free DNA
Anatoli Kustanovich et al.
CANCER BIOLOGY & THERAPY (2019)
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
Mohamed F. Attia et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
DNMT Inhibitors Increase Methylation in the Cancer Genome
Anil K. Giri et al.
FRONTIERS IN PHARMACOLOGY (2019)
Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression
Liyan Wang et al.
MOLECULAR CANCER (2019)
Exosomal circRNAs: biogenesis, effect and application in human diseases
Yangxia Wang et al.
MOLECULAR CANCER (2019)
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
Karla Rubio et al.
NATURE COMMUNICATIONS (2019)
HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
Carolyn M. Klinge et al.
SCIENTIFIC REPORTS (2019)
Novel insights into breast cancer progression and metastasis: A multidisciplinary opportunity to transition from biology to clinical oncology
Manuel Scimeca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer
Su-Jin Jeong et al.
CANCERS (2019)
The Regulatory Role of MicroRNAs in Breast Cancer
Hui-Yi Loh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
Patrick L. Leslie et al.
NATURE COMMUNICATIONS (2019)
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Mohammad Mijanur Rahman et al.
CELLS (2019)
Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications
Ana Godoy-Ortiz et al.
FRONTIERS IN ONCOLOGY (2019)
Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
Okhil K. Nag et al.
PHARMACEUTICS (2019)
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
Dnyaneshwar Kalyane et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Prognostic and Predictive Epigenetic Biomarkers in Oncology
Katarzyna Kaminska et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019
Annalisa Buniello et al.
NUCLEIC ACIDS RESEARCH (2019)
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers
Maria Panagopoulou et al.
ONCOGENE (2019)
Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p
Zihao Liu et al.
CELL DEATH & DISEASE (2019)
The size of cell-free mitochondrial DNA in blood is inversely correlated with tumor burden in cancer patients
Qin An et al.
PRECISION CLINICAL MEDICINE (2019)
The emerging roles and functions of circular RNAs and their generation
Chun-Ying Yu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
Daniel Fernandez-Garcia et al.
BREAST CANCER RESEARCH (2019)
Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application
Zhen Zhao et al.
LAB ON A CHIP (2019)
Kinetics of Plasma Cell-Free DNA and Creatine Kinase in a Canine Model of Tissue Injury
I. J. Wilson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2018)
Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
Nadda Muhamad et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A
Madhuram Khandelwal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization
Indrabahadur Singh et al.
NATURE GENETICS (2018)
Replicability and Prediction: Lessons and Challenges from GWAS
Urko M. Marigorta et al.
TRENDS IN GENETICS (2018)
Function of GCN5 in the TGF-1-induced epithelial-to-mesenchymal transition in breast cancer
Liming Zhao et al.
ONCOLOGY LETTERS (2018)
The CRISPR tool kit for genome editing and beyond
Mazhar Adli
NATURE COMMUNICATIONS (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Prominent role of histone lysine demethylases in cancer epigenetics and therapy
Avilala Janardhan et al.
Oncotarget (2018)
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
Bo Chen et al.
THERANOSTICS (2018)
Histone Modifications: Insights into Their Influence on Gene Expression
Bruce Stillman
CELL (2018)
Rat BodyMap transcriptomes reveal unique circular RNA features across tissue types and developmental stages
Tong Zhou et al.
RNA (2018)
The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease
Celine Tiffon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
SETD3 protein is the actin-specific histidine N-methyltransferase
Sebastian Kwiatkowski et al.
ELIFE (2018)
A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
Sofia Salta et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
Yijuan Zhang et al.
ACS NANO (2017)
Smart nanoparticles improve therapy for drug resistant tumors by overcoming pathophysiological barriers
Jian-ping Liu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Nanoparticles for tumor immunotherapy
Xinlong Zang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
A conduit to metastasis: circulating tumor cell biology
Douglas S. Micalizzi et al.
GENES & DEVELOPMENT (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Biomolecular condensates: organizers of cellular biochemistry
Salman F. Banani et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
Roberta Mazzone et al.
CLINICAL EPIGENETICS (2017)
The LIN28/let-7 Pathway in Cancer
Julien Balzeau et al.
FRONTIERS IN GENETICS (2017)
Circulating extracellular DNA levels are acutely elevated in ischaemic stroke and associated with innate immune system activation
Grant C. O'Connell et al.
BRAIN INJURY (2017)
10 Years of GWAS Discovery: Biology, Function, and Translation
Peter M. Visscher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Extensive translation of circular RNAs driven by N6-methyladenosine
Yun Yang et al.
CELL RESEARCH (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
DNA methyltransferases and their roles in tumorigenesis
Wu Zhang et al.
BIOMARKER RESEARCH (2017)
Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Eunah Kim et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Elevated Cell-Free DNA Measured by a Simple Assay Is Associated With Increased Rate of Colorectal Cancer Relapse
David Czeiger et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases
Hanna Dillekas et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Elena Ceccacci et al.
BRITISH JOURNAL OF CANCER (2016)
Origins, structures, and functions of circulating DNA in oncology
A. R. Thierry et al.
CANCER AND METASTASIS REVIEWS (2016)
Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation
Niek G. J. Leus et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Decoding the usefulness of non-coding RNAs as breast cancer markers
Maria Amorim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies
Stanislav Volik et al.
MOLECULAR CANCER RESEARCH (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells
Tetsuro Kamiya et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances
Gustaw Lech et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Maintenance of Epigenetic Information
Genevieve Almouzni et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Generation of TALEN-mediated FH knockout rat model
Dandan Yu et al.
ONCOTARGET (2016)
The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1
Yanyan Gao et al.
SCIENTIFIC REPORTS (2016)
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
Tingting Jiang et al.
PLOS MEDICINE (2016)
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
Sean W Fanning et al.
eLife (2016)
Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis
Elima Jedy-Agba et al.
LANCET GLOBAL HEALTH (2016)
Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
Cristina Chamorro et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Plasma extracellular RNA profiles in healthy and cancer patients
Tiezheng Yuan et al.
SCIENTIFIC REPORTS (2016)
circRNADb: A comprehensive database for human circular RNAs with protein-coding annotations
Xiaoping Chen et al.
SCIENTIFIC REPORTS (2016)
Breast Cancer Subtypes: Morphologic and Biologic Characterization
Shahla Masood
WOMENS HEALTH (2016)
Elasticity of Nanopartides Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting
Aaron C. Anselmo et al.
ACS NANO (2015)
Health system delay and its effect on clinical stage of breast cancer: Multicenter study
Karla Unger-Saldana et al.
CANCER (2015)
HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events
Claudio R. Alarcon et al.
CELL (2015)
Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN
Qurrat Ul Ain et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Miguel Vizoso et al.
NATURE MEDICINE (2015)
DNA methylation pathways and their crosstalk with histone methylation
Jiamu Du et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5
Ulrike Mock et al.
NUCLEIC ACIDS RESEARCH (2015)
Role of epigenetic modifications in luminal breast cancer
Hany A. Abdel-Hafiz et al.
EPIGENOMICS (2015)
Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis
Karin van Veldhoven et al.
CLINICAL EPIGENETICS (2015)
Bilateral synchronous carcinoma breast- a rare case presentation
Vijay Kumar Shankarrao Kappikeri et al.
SPRINGERPLUS (2015)
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
John A. Zuris et al.
NATURE BIOTECHNOLOGY (2015)
EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
Nithya Subramanian et al.
PLOS ONE (2015)
Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway
Nehad M Alajez et al.
Oncotarget (2015)
Rare types of breast carcinoma
Daiva Gudaviciene et al.
OPEN MEDICINE (2015)
Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer
Gianluca Severi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones
Thomas R. Cech et al.
CELL (2014)
Differences in DNA methylation by extent of breast cancer family history in unaffected women
Lissette Delgado-Cruzata et al.
EPIGENETICS (2014)
Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators
Hui Yang et al.
FASEB JOURNAL (2014)
TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
B. Berdien et al.
GENE THERAPY (2014)
Evading Immune Cell Uptake and Clearance Requires PEG Grafting at Densities Substantially Exceeding the Minimum for Brush Conformation
Qi Yang et al.
MOLECULAR PHARMACEUTICS (2014)
The dynamic epitranscriptome: N6-methyladenosine and gene expression control
Kate D. Meyer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
Yujia Cai et al.
ELIFE (2014)
Delay in breast cancer: implications for stage at diagnosis and survival
Lee Caplan
FRONTIERS IN PUBLIC HEALTH (2014)
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
Berit Maria Mueller et al.
BMC CANCER (2013)
MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1
Laisheng Li et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2013)
Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
Luis M. Valor et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
MicroRNAs in adipose tissue: their role in adipogenesis and obesity
C. Hilton et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins
Sameer Mirza et al.
JOURNAL OF BREAST CANCER (2013)
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Daniel Quiat et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
TALEN-mediated editing of the mouse Y chromosome
Haoyi Wang et al.
NATURE BIOTECHNOLOGY (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
Maarten Holkers et al.
NUCLEIC ACIDS RESEARCH (2013)
A Review of Breast Cancer Care and Outcomes in Latin America
Nahila Justo et al.
ONCOLOGIST (2013)
Circular RNAs are abundant, conserved, and associated with ALU repeats
William R. Jeck et al.
RNA (2013)
Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
Kevin Brennan et al.
CANCER RESEARCH (2012)
Med1 plays a critical role in the development of tamoxifen resistance
Arumugam Nagalingam et al.
CARCINOGENESIS (2012)
High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers
X. Hou et al.
EJSO (2012)
Biomarkers in Breast Cancer - An Update
M. Schmidt et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2012)
The Epigenotype
C. H. Waddington
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer
Chenfang Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma
Zhi-Wei Liao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F
Sarah Jurmeister et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
被撤回的出版物: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3 (Retracted article. See vol. 63, pg. 180, 2016)
Nicolas Herranz et al.
MOLECULAR CELL (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Functional screening identifies miRNAs inducing cardiac regeneration
Ana Eulalio et al.
NATURE (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types
Julia Salzman et al.
PLOS ONE (2012)
Identification of Combinatorial Patterns of Post-Translational Modifications on Individual Histones in the Mouse Brain
Ry Y. Tweedie-Cullen et al.
PLOS ONE (2012)
Efficient TALEN-mediated gene knockout in livestock
Daniel F. Carlson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Jinjun Shi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation
Takashi Iwamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway
Nehad M. Alajez et al.
CANCER RESEARCH (2011)
Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification
Minjia Tan et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Histone arginine methylation
Alessandra Di Lorenzo et al.
FEBS LETTERS (2011)
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer
Kim J. Png et al.
GENES & DEVELOPMENT (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma
Mei Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller et al.
NATURE BIOTECHNOLOGY (2011)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
Histone onco-modifications
J. Fullgrabe et al.
ONCOGENE (2011)
Epigenetics and lifestyle
Jorge Alejandro Alegra-Torres et al.
EPIGENOMICS (2011)
MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a
Yanqi Chang et al.
NATURE COMMUNICATIONS (2011)
MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
Shuai Jiang et al.
CANCER RESEARCH (2010)
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
Peter J. O'Donovan et al.
CARCINOGENESIS (2010)
Hdac1 and Hdac2 Act Redundantly to Control p63 and p53 Functions in Epidermal Progenitor Cells
Matthew LeBoeuf et al.
DEVELOPMENTAL CELL (2010)
Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women
Jo-Heon Kim et al.
GYNECOLOGIC ONCOLOGY (2010)
Nanoparticulate drug delivery systems for cancer chemotherapy
Ranendra N. Saha et al.
MOLECULAR MEMBRANE BIOLOGY (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment
Jan H. Beumer et al.
CURRENT CLINICAL PHARMACOLOGY (2010)
Clinical Toxicities of Histone Deacetylase Inhibitors
Srividya Subramanian et al.
PHARMACEUTICALS (2010)
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
J. M. Flanagan et al.
BREAST CANCER RESEARCH (2010)
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
A Pharmacy Preregistration Course Using Online Teaching and Learning Methods
Rohan A. Elliott et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2009)
DNA Methylation of Cancer Genome
Hoi-Hung Cheung et al.
BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS (2009)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
microRNA-205 Regulates HER3 in Human Breast Cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2009)
Suppression of cell growth and invasion by miR-205 in breast cancer
Hailong Wu et al.
CELL RESEARCH (2009)
Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
David S. Schrump
CLINICAL CANCER RESEARCH (2009)
Hormones as epigenetic signals in developmental programming
Abigail L. Fowden et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Drug targeting and tumor heterogeneity
You Han Bae
JOURNAL OF CONTROLLED RELEASE (2009)
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Steven D. Perrault et al.
NANO LETTERS (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
Nalinie S. Wickramasinghe et al.
NUCLEIC ACIDS RESEARCH (2009)
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Paolo Decuzzi et al.
PHARMACEUTICAL RESEARCH (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
Concordant Regulation of Translation and mRNA Abundance for Hundreds of Targets of a Human microRNA
David G. Hendrickson et al.
PLOS BIOLOGY (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
Liangfang Zhang et al.
ACS NANO (2008)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Advances in Breast Cancer: Pathways to Personalized Medicine
Olufunmilayo I. Olopade et al.
CLINICAL CANCER RESEARCH (2008)
The role of histone deacetylases in prostate cancer
Ata Abbas et al.
EPIGENETICS (2008)
Class IIA HDACs in the regulation of neurodegeneration
Nazanin Majdzadeh et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Andrew J. Wilson et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
The impact of microRNAs on protein output
Daehyun Baek et al.
NATURE (2008)
Widespread changes in protein synthesis induced by microRNAs
Matthias Selbach et al.
NATURE (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape
Sumit Isharwal et al.
PROSTATE (2008)
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
Lisa B. Frankel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Switching from repression to activation: MicroRNAs can up-regulate translation
Shobha Vasudevan et al.
SCIENCE (2007)
Multivalent engagement of chromatin modifications by linked binding modules
Alexander J. Ruthenburg et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Biologic and clinical characteristics of breast cancer with single hormone receptor-positive phenotype
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Mechanisms of epigenetic inheritance
Cyrus Martin et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
Shuomin Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation
Qun Zhou et al.
CANCER BIOLOGY & THERAPY (2007)
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Paola Gallinari et al.
CELL RESEARCH (2007)
Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits
Ana M. M. Oliveira et al.
LEARNING & MEMORY (2007)
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
Matthew J. Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
KLF4, p21 and context-dependent opposing forces in cancer
BD Rowland et al.
NATURE REVIEWS CANCER (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast
ZH Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies
F Lyko et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability
D Venturoli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1
BH Huang et al.
CELL DEATH AND DIFFERENTIATION (2005)
Histone acetylation and deacetylation: importance in inflammatory lung diseases
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Sirtuins: Sir2-related NAD-dependent protein deacetylases
BJ North et al.
GENOME BIOLOGY (2004)
DNA methyltransferase and demethylase in human prostate cancer
SK Patra et al.
MOLECULAR CARCINOGENESIS (2002)
Expression profile of histone deacetylase 1 in gastric cancer tissues
JH Choi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
S Mizuno et al.
BLOOD (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)